Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

GALMED PHARMACEUTICALS LTD.

(GLMD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société GALMED PHARMACEUTICALS LTD.
11/08Galmed Pharmaceuticals Provides Additional Positive Data from the Open Label Part of AR..
PU
11/08GALMED PHARMACEUTICALS : Q3 Earnings Snapshot
AQ
11/01—Data demonstrates that treatment with Aramchol 300mg BID resulted in clinically ..
PU
10/12GALMED PHARMACEUTICALS : Results of Galmed's Phase 2b ARREST Trial of Aramchol Published i..
PU
10/11GALMED PHARMACEUTICALS : Results of Galmed's Phase 2b ARREST Trial of Aramchol Published i..
PR
08/19GALMED PHARMACEUTICALS : Announces Publication in “The Journal of Autoimmunity&rdquo..
PU
08/16GALMED PHARMACEUTICALS : MHRA Agrees with Galmed's Plan to use Aramchol meglumine in the R..
PU
08/05GALMED PHARMACEUTICALS : Q2 Earnings Snapshot
AQ
08/02GALMED PHARMACEUTICALS : FDA Agrees with Galmed's Plan to use Aramchol Meglumine in the Ra..
PU
08/02GALMED PHARMACEUTICALS : FDA Agrees with Galmed's Plan to use Aramchol Meglumine in the Ra..
PR
07/19GALMED PHARMACEUTICALS : Form 6-K)
PU
05/13GALMED PHARMACEUTICALS : Q1 Earnings Snapshot
AQ
05/13GALMED PHARMACEUTICALS : Provides Business Updates and Reports First Quarter 2021 Financia..
PR
04/13Ascentage Pharma Appoints Renowned Oncologist Dr. David Sidransky, MD, to its Board as ..
AQ
2019GALMED PHARMACEUTICALS : to Present New Data on Aramchol Effect on Glucose Metabolism, MoA..
PU
2019GALMED PHARMACEUTICALS : Reports Fourth Quarter and Full Year 2018 Financial Results and P..
PU
2018GALMED PHARMACEUTICALS : Phase 2 Data for Galmed Pharmaceutical's Aramchol™ in Non-A..
PU
2018GALMED PHARMACEUTICALS : Announces a Late-Breaking Abstract on Aramchol™ to be Prese..
PU
2018GALMED PHARMACEUTICALS : to Host Post-EASL Key Opinion Leader Call on the Scientific Ratio..
PU
2017GALMED PHARMACEUTICALS : Reports Third Quarter 2017 Financial Results and Provides Busines..
PU
2017GALMED PHARMACEUTICALS : Announces Publication of Data on Aramchol™ Mechanism of Act..
PU
2017GALMED PHARMACEUTICALS : to Present at International Liver Congress Data that Shows Aramch..
PU
2016GALMED PHARMACEUTICALS : and the University of California, San Diego Enter into an Investi..
PU
2016GALMED PHARMACEUTICALS : and SAMIL Pharm Sign a License Agreement for the Commercializatio..
PU
2016GALMED PHARMACEUTICALS : and Weizmann Institute of Science to enter a research collaborati..
PU
2016GALMED PHARMACEUTICALS : Mount Sinai and Galmed Pharmaceuticals to Collaborate in an Inves..
PU
2016GALMED PHARMACEUTICALS : Aramchol™ Demonstrates Significant Anti-Fibrotic Effect in ..
PU
2015GALMED PHARMACEUTICALS : NextBigThingInvestor.com Releases Two-Part Interview With Tobin S..
MW
Upcoming event on GALMED PHARMACEUTICALS LTD.